🎗️ Проект автоматически собирает и публикует онкологические новости из проверенных медицинских источников — 24/7, со ссылкой на первоисточник
Английские новости переводятся автоматически

🎗️Лента новостей

Онкология

PAPILLON trial: Amivantamab plus chemotherapy adds months of survival in rare lung cancer

Final results from the landmark PAPILLON trial, which changed the standard of care for a difficult-to-treat rare form of lung cancer, confirm that amivantamab, when added to chemotherapy, provides durable clinical benefit and the longest median overall survival reported to date for people with the disease.

Онкология

Closing the colorectal screening gap starts with matching options to patient preference

Clinicians have more colorectal cancer screening options than ever before. The challenge is helping more eligible patients complete them. Colorectal cancer screening has the power to change patient outcomes by detecting disease earlier and, in some cases, preventing cancer altogether. Yet despite well-established…